Detalles de la búsqueda
1.
Bortezomib with chemotherapy is highly active in advanced B-precursor acute lymphoblastic leukemia: Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study.
Blood
; 120(2): 285-90, 2012 Jul 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-22653976
2.
Phase I study of bortezomib combined with chemotherapy in children with relapsed childhood acute lymphoblastic leukemia (ALL): a report from the therapeutic advances in childhood leukemia (TACL) consortium.
Pediatr Blood Cancer
; 55(2): 254-9, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20582937
Resultados
1 -
2
de 2
1
Próxima >
>>